Literature DB >> 32124173

Efficient isolation and proliferation of human adipose-derived mesenchymal stromal cells in xeno-free conditions.

Natalia Langenfeld Fuoco1, Rafael Guilen de Oliveira1, Monica Yonashiro Marcelino1, Talita Stessuk1, Marna Eliana Sakalem2, Denis Aloisio Lopes Medina3, Waldir Pereira Modotti3, Andresa Forte4, João Tadeu Ribeiro-Paes5,6.   

Abstract

Classical methods used for culture of adipose-derived mesenchymal stromal cells (ADSCs) use xenobiotic components, which may present a potential risk for biological contamination and/or elicit immunological reactions. Therefore, the aim of this study was to establish a xeno-free methodology for the isolation and proliferation of human ADSCs (hADSCs). hADSCs were isolated by enzymatic digestion or mechanical dissociation and cultured in the presence of fetal bovine serum or human platelet lysate. Proliferation curves were performed as a function of time from the cell culture and used to calculate the population doubling time. Immunophenotyping and differentiation tests were used to identify and characterize the hADSCs. Human ADSCs isolated and cultured in conventional or xenobiotic-free conditions peaked at different days but achieved similar maximum proliferation. The hADSCs differentiation ability was similar in all groups. The characterization of hADSCs by flow cytometry showed low contamination of the cultures by other cell types. The xenobiotic-free methodology described in this study is a feasible and reproducible alternative for isolation and proliferation of hADSCs. This methodology is in accordance with the recommendations of the National Health Surveillance Agency, which proposes avoidance of xenobiotic products.

Entities:  

Keywords:  Adipose tissue; Fetal bovine serum (FBS); Mesenchymal stromal cells; Platelet lysate; Stem cells

Mesh:

Substances:

Year:  2020        PMID: 32124173     DOI: 10.1007/s11033-020-05322-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

1.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 2.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

3.  A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates.

Authors:  Francesca Bianchi; Margherita Maioli; Erika Leonardi; Elena Olivi; Gianandrea Pasquinelli; Sabrina Valente; Armando J Mendez; Camillo Ricordi; Mirco Raffaini; Carlo Tremolada; Carlo Ventura
Journal:  Cell Transplant       Date:  2012-10-08       Impact factor: 4.064

4.  Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells.

Authors:  Martina Bernardi; Elena Albiero; Alberta Alghisi; Katia Chieregato; Chiara Lievore; Domenico Madeo; Francesco Rodeghiero; Giuseppe Astori
Journal:  Cytotherapy       Date:  2013-04-24       Impact factor: 5.414

Review 5.  Large-scale production of human mesenchymal stem cells for clinical applications.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Reynold D Wuerth; Lawrence Rosenberg; Leo A Behie
Journal:  Biotechnol Appl Biochem       Date:  2012 Mar-Apr       Impact factor: 2.431

6.  Decreasing variability in your cell culture.

Authors:  Aaron Stein
Journal:  Biotechniques       Date:  2007-08       Impact factor: 1.993

7.  Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use.

Authors:  Stig-Frederik Trojahn Kølle; Roberto S Oliveri; Peter V Glovinski; Maria Kirchhoff; Anders Bruun Mathiasen; Jens Jørgen Elberg; Peter Stemann Andersen; Krzysztof Tadeusz Drzewiecki; Anne Fischer-Nielsen
Journal:  Cytotherapy       Date:  2013-04-17       Impact factor: 5.414

8.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

9.  Collagenase lot selection and purification for adipose tissue digestion.

Authors:  S K Williams; S McKenney; B E Jarrell
Journal:  Cell Transplant       Date:  1995 May-Jun       Impact factor: 4.139

Review 10.  Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy.

Authors:  Jajini Varghese; Michelle Griffin; Afshin Mosahebi; Peter Butler
Journal:  Stem Cell Res Ther       Date:  2017-02-28       Impact factor: 6.832

View more
  3 in total

Review 1.  Mesenchymal stem cells for restoring endometrial function: An infertility perspective.

Authors:  Ruttachuk Rungsiwiwut; Pramuan Virutamasen; Kamthorn Pruksananonda
Journal:  Reprod Med Biol       Date:  2020-07-20

Review 2.  Adipose-Derived Stem Cells: Current Applications and Future Directions in the Regeneration of Multiple Tissues.

Authors:  Jiaxin Zhang; Yuzhe Liu; Yutong Chen; Lei Yuan; He Liu; Jincheng Wang; Qiran Liu; Yan Zhang
Journal:  Stem Cells Int       Date:  2020-12-10       Impact factor: 5.443

3.  Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: comparison with fetal bovine serum and considerations on the production protocol.

Authors:  Silvia Palombella; Carlotta Perucca Orfei; Greta Castellini; Silvia Gianola; Silvia Lopa; Maddalena Mastrogiacomo; Matteo Moretti; Laura de Girolamo
Journal:  Stem Cell Res Ther       Date:  2022-04-04       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.